Technical Analysis for QPT - Quest Pharmatech Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 20 DMA | Bearish | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Calm After Storm | Range Contraction | -14.29% | |
| Narrow Range Bar | Range Contraction | -14.29% | |
| Inside Day | Range Contraction | -14.29% | |
| Wide Bands | Range Expansion | -14.29% | |
| Gapped Up | Strength | -14.29% |
| Alert | Time |
|---|---|
| Down 1 ATR | 7 days ago |
| Fell Below Previous Day's Low | 7 days ago |
| 5x Volume Pace | 7 days ago |
| 3x Volume Pace | 7 days ago |
| 2x Volume Pace | 7 days ago |
Get this analysis on your stocks daily!
- Earnings date: 2024-12-11
Quest Pharmatech Inc. Description
Quest PharmaTech Inc. is a Canada-based pharmaceutical company. The Company, through its subsidiary, OncoQuest Inc., is developing immunotherapies for cancer treatment. It operates through two segments: biopharmaceutical/pharmaceutical products and consumer/cosmetic products. OncoQuest's technology platform includes a panel of tumor antigen specific monoclonal immunoglobulins, including CA125, MUC1, PSA, and Her2/neu, and the application of combinatorial immunotherapy. OncoQuest's lead product, oregovomab, is undergoing a Phase IIb clinical trial involving approximately 80 ovarian cancer patients in Italy and the United States. OncoQuest's pipeline of product candidates consists of four other monoclonal antibodies targeting certain tumor antigens that are presented in a range of cancers, including such cancers as breast, lung, pancreas, stomach and prostate. It also markets consumer health products around the world, including Bellus Skin serum, an anti-wrinkle skin care product.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Medicine Pipe Pharma Pipeline Pharmaceutical Clinic Cancer RTT Skin Therapy Biopharmaceutical Pharmaceutical Products Clinical Trial Cancers Tumor Antigen Immunotherapy Treatment Of Cancer Antibodies Immunotherapies Breast Cancer Consumer Health Products Cosmetic Products Monoclonal Antibodies
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.105 |
| 52 Week Low | 0.015 |
| Average Volume | 89,772 |
| 200-Day Moving Average | 0.048 |
| 50-Day Moving Average | 0.027 |
| 20-Day Moving Average | 0.031 |
| 10-Day Moving Average | 0.031 |
| Average True Range | 0.004 |
| RSI (14) | 50.25 |
| ADX | 8.0 |
| +DI | 30.035 |
| -DI | 32.813 |
| Chandelier Exit (Long, 3 ATRs) | 0.027 |
| Chandelier Exit (Short, 3 ATRs) | 0.038 |
| Upper Bollinger Bands | 0.037 |
| Lower Bollinger Band | 0.024 |
| Percent B (%b) | 0.46 |
| BandWidth | 40.656 |
| MACD Line | 0.001 |
| MACD Signal Line | 0.001 |
| MACD Histogram | 0.0002 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.030 | ||||
| Resistance 3 (R3) | 0.030 | 0.030 | 0.030 | ||
| Resistance 2 (R2) | 0.030 | 0.030 | 0.030 | 0.030 | |
| Resistance 1 (R1) | 0.030 | 0.030 | 0.030 | 0.030 | 0.030 |
| Pivot Point | 0.030 | 0.030 | 0.030 | 0.030 | 0.030 |
| Support 1 (S1) | 0.030 | 0.030 | 0.030 | 0.030 | 0.030 |
| Support 2 (S2) | 0.030 | 0.030 | 0.030 | 0.030 | |
| Support 3 (S3) | 0.030 | 0.030 | 0.030 | ||
| Support 4 (S4) | 0.030 |
